论文信息 - Pomalidomide, Dexamethasone, and Daratumumab after Lenalidomide Treatment in Relapsed Refractory Multiple Myeloma: Updated Results from an Open-Label, Multicenter, Phase 2 Trial - 字舞流文

Pomalidomide, Dexamethasone, and Daratumumab after Lenalidomide Treatment in Relapsed Refractory Multiple Myeloma: Updated Results from an Open-Label, Multicenter, Phase 2 Trial

D. Siegel | D. Reece | A. Agarwal | G. Schiller | M. Sebag | N. Bahlis | C. Seet | K. Song | J. Matous | B. Anz | S. Ganguly | C. Samaras | J. Berdeja | D. Quick | M. Bar | M. Acosta-Rivera | Weiyuan Chung | G. Fonseca | Kim Lee